Ad is loading...
HYPMY
Price
$3.36
Change
-$0.20 (-5.62%)
Updated
Nov 15 closing price
KMDA
Price
$5.81
Change
-$0.05 (-0.85%)
Updated
Nov 15 closing price
86 days until earnings call
Ad is loading...

HYPMY vs KMDA

Header iconHYPMY vs KMDA Comparison
Open Charts HYPMY vs KMDABanner chart's image
Hypera SA
Price$3.36
Change-$0.20 (-5.62%)
Volume$40.97K
CapitalizationN/A
Kamada
Price$5.81
Change-$0.05 (-0.85%)
Volume$29.28K
CapitalizationN/A
HYPMY vs KMDA Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
HYPMY vs. KMDA commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPMY is a Hold and KMDA is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (HYPMY: $3.36 vs. KMDA: $5.81)
Brand notoriety: HYPMY and KMDA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HYPMY: 14% vs. KMDA: 81%
Market capitalization -- HYPMY: $5.79B vs. KMDA: $306.49M
HYPMY [@Pharmaceuticals: Other] is valued at $5.79B. KMDA’s [@Pharmaceuticals: Other] market capitalization is $306.49M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPMY’s FA Score shows that 1 FA rating(s) are green whileKMDA’s FA Score has 0 green FA rating(s).

  • HYPMY’s FA Score: 1 green, 4 red.
  • KMDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both HYPMY and KMDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 5 TA indicator(s) are bullish.

  • KMDA’s TA Score: 5 bullish, 5 bearish.

Price Growth

HYPMY (@Pharmaceuticals: Other) experienced а -7.77% price change this week, while KMDA (@Pharmaceuticals: Other) price change was -3.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

KMDA is expected to report earnings on Feb 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPMY($5.79B) has a higher market cap than KMDA($306M). KMDA has higher P/E ratio than HYPMY: KMDA (37.43) vs HYPMY (15.95). KMDA YTD gains are higher at: -5.065 vs. HYPMY (-51.681). HYPMY has higher annual earnings (EBITDA): 2.86B vs. KMDA (22.4M). HYPMY has higher revenues than KMDA: HYPMY (7.75B) vs KMDA (143M).
HYPMYKMDAHYPMY / KMDA
Capitalization5.79B306M1,892%
EBITDA2.86B22.4M12,750%
Gain YTD-51.681-5.0651,020%
P/E Ratio15.9537.4343%
Revenue7.75B143M5,420%
Total CashN/A55.6M-
Total DebtN/A8.82M-
FUNDAMENTALS RATINGS
HYPMY vs KMDA: Fundamental Ratings
HYPMY
KMDA
OUTLOOK RATING
1..100
5043
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
5776
PRICE GROWTH RATING
1..100
9345
P/E GROWTH RATING
1..100
9092
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPMY's Valuation (8) in the null industry is somewhat better than the same rating for KMDA (64) in the Biotechnology industry. This means that HYPMY’s stock grew somewhat faster than KMDA’s over the last 12 months.

KMDA's Profit vs Risk Rating (87) in the Biotechnology industry is in the same range as HYPMY (100) in the null industry. This means that KMDA’s stock grew similarly to HYPMY’s over the last 12 months.

HYPMY's SMR Rating (57) in the null industry is in the same range as KMDA (76) in the Biotechnology industry. This means that HYPMY’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's Price Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for HYPMY (93) in the null industry. This means that KMDA’s stock grew somewhat faster than HYPMY’s over the last 12 months.

HYPMY's P/E Growth Rating (90) in the null industry is in the same range as KMDA (92) in the Biotechnology industry. This means that HYPMY’s stock grew similarly to KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDA
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Momentum
ODDS (%)
Bearish Trend 3 days ago
71%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 6 days ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Ad is loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRJIX10.94-0.01
-0.09%
Morgan Stanley Multi-Asset Real Return I
PGSYX20.00-0.12
-0.60%
Pioneer Global Sustainable Equity Y
SVFYX83.94-0.71
-0.84%
Smead Value Y
CRLVX10.05-0.10
-0.99%
Catholic Rspnsbl Invstmnts Intl Eq Inv
FIFPX23.41-0.36
-1.51%
Fidelity Advisor Founders M

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and AYRWF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and AYRWF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
-5.72%
AYRWF - HYPMY
23%
Poorly correlated
-1.28%
PLNH - HYPMY
21%
Poorly correlated
N/A
CPIX - HYPMY
20%
Poorly correlated
-5.00%
GLASF - HYPMY
20%
Poorly correlated
-0.38%
KMDA - HYPMY
20%
Poorly correlated
-0.85%
More

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and NXSCF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and NXSCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-0.85%
NXSCF - KMDA
27%
Poorly correlated
-3.18%
SGIOY - KMDA
27%
Poorly correlated
-0.13%
ACET - KMDA
22%
Poorly correlated
-9.82%
INCR - KMDA
22%
Poorly correlated
-5.87%
RDY - KMDA
22%
Poorly correlated
-0.49%
More